Vascular & Endovascular

This channel includes news on non-coronary vascular disease and therapies. These include peripheral artery disease (PAD), abdominal and thoracic aortic aneurysm (AAA and TAA), aortic dissection, pulmonary embolism (PE), critical limb ischemia (CLI), carotid artery and stroke interventions, venous interventions, deep vein thrombosis (DVT), and interventional radiology therapies. The focus on most of these therapies is minimally invasive, catheter-based procedures performed in a cath lab.

Johnson & Johnson pauses use of FDA-approved PFA system to investigate patient complications
Johnson & Johnson MedTech's Varipulse PFA system has been linked to multiple reports of "neurovascular events" in patients. The company hopes to share more information in the days ahead.
Stryker acquires Inari Medical for $4.9B
Stryker, a global medtech company based out of Michigan, has kicked off 2025 with a bit of excitement. The company says Inari’s peripheral vascular portfolio is highly complementary to its own neurovascular portfolio.
‘Fundamental for all patients’: Exploring the benefits of palliative care for stroke survivors
Approximately 800,000 strokes occur each year in the United States alone. A majority of people survive, due in part to key advances in patient care over the years, but they often go forward without receiving the long-term help they need to recover and thrive.
Advancing AI for vascular surgery will require a commitment to data integrity
For artificial intelligence to truly transform care, the healthcare industry must address certain challenges. Jens Eldrup-Jorgensen, MD, a veteran vascular surgeon and member of the Society for Vascular Surgery, explains in a guest editorial.
Industry concerns over paclitaxel-coated devices may have put PAD patients at risk
Back in 2019, the FDA issued a warning about the use of paclitaxel-coated devices when treating peripheral artery disease. The agency took back that warning in 2023, but it appears to have made a significant impact on patient care.

Stimulants increase the short-term risk of heart attack, stroke, arrhythmia in older patients

Researchers emphasized that safety considerations should be included when stimulants are prescribed to older adults.

October 29, 2021

IVUS-guided PCI boosts outcomes for AMI patients

A new study in JACC: Cardiovascular Interventions highlights multiple long-term benefits of IVUS-guided PCI compared to angiography-guided PCI.

October 28, 2021

CAC scores not always reliable for ruling out obstructive CAD

Researchers tracked data from more than 23,000 patients, encountering an 'apparent paradox' along the way.

October 27, 2021

Patients often 'orphaned' after aortic dissection, increasing their risk of complications

“These patients are at ongoing risk for aortic complications, reintervention and death," one researcher said. "What’s particularly alarming is that these risks do not subside over time."

October 27, 2021

Cardiologists use TTE to screen CAD patients for abdominal aortic aneurysms

TTE, researchers wrote, was "as good as abdominal ultrasound" when it came to screening for AAA.

October 26, 2021

Many nonvalvular AFib patients skip DOAC therapy altogether

The study's authors hope their work can help with the development of new interventions that target this issue.

October 25, 2021

Comparing common treatments for posterior circulation stroke

The new study, published in Stroke, included data related to aspiration and stent retriever thrombectomy.

October 25, 2021

“Thrombosis interrupts and delays venous therapy, increases cost of care and can lead to significant adverse patient outcomes," researchers said.

October 19, 2021

Vascular & Endovascular

Johnson & Johnson pauses use of FDA-approved PFA system to investigate patient complications

Stryker acquires Inari Medical for $4.9B

‘Fundamental for all patients’: Exploring the benefits of palliative care for stroke survivors

Advancing AI for vascular surgery will require a commitment to data integrity

Industry concerns over paclitaxel-coated devices may have put PAD patients at risk